ArticleBJPsych advances2026
Ovarian hormones, hormonal contraceptives and reward processing.
Article in BJPsych advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Research on ovarian hormones reveals an increasingly important role in brain function. This includes reward processing, the umbrella phrase for functions that promote motivation for, response to, and learning about rewards. This paper seeks to provide a concise overview of how ovarian hormones influence reward function, with a specific focus surrounding the ovarian hormone derivatives found in hormonal contraception. Despite the complexity of findings, the research suggests a general pattern in which estradiol may promote multiple reward functions and progesterone often appears to play an inhibitory role. Allopregnanolone's effects on reward functions appear to be concentration dependent and follow an inverted-U. Limited research on hormonal contraception suggests that these agents may interfere with reward neurobiology, potentially contributing to deficits in sexual desire and positive mood, though some individuals may be more susceptible than others. Effects of ovarian hormones and their derivatives on reward processing have multiple clinical implications. These are discussed as it relates to hormonal therapy in menopause, avoiding side effects with hormonal contraception, and ongoing research on the use of progesterone in substance use disorders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.